Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position
申请人:FRORMANN Sven
公开号:US20080293749A1
公开(公告)日:2008-11-27
Pyrrolidine(thi)one compounds substituted by heterocyclic substituents in the 3-position, their preparation and use in pharmaceutical compositions, in particular as immunomodulators for treatment and/or inhibition of inflammatory and autoimmune diseases and haematological-oncological diseases.
IN 3-POSITION HETEROCYCLISCH SUBSTITUIERTE PYRROLIDIN(THI)ONE
申请人:Grünenthal GmbH
公开号:EP1957481A1
公开(公告)日:2008-08-20
[DE] IN 3-POSITION HETEROCYCLISCH SUBSTITUIERTE PYRROLIDIN(THI)ONE<br/>[EN] PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION<br/>[FR] PYRROLIDIN(THI)ONES A SUBSTITUTION HETEROCYCLIQUE EN POSITION 3
申请人:GRUENENTHAL GMBH
公开号:WO2007062817A1
公开(公告)日:2007-06-07
[EN] Disclosed are pyrrolidin(thi)ones which are heterocyclically substituted in 3-position, the production thereof, and the use thereof in medicaments, especially as immune modulators for the treatment and/or prevention of inflammatory and autoimmune diseases as well as hematologic-oncologic diseases. [FR] La présente invention concerne des pyrrolidin(thi)ones à substitution hétérocyclique en position 3, leur préparation et leur utilisation dans des produits pharmaceutiques, en particulier en tant qu'immunomodulateurs pour traiter et/ou prévenir des troubles inflammatoires et auto-immuns, ainsi que des troubles hématologiques et oncologiques. [DE] Es werden in 3-Position heterocyclisch substituierte Pyrrolidin(thi)one, ihre Herstellung und Verwendung in Arzneimitteln, insbesondere als Immunmodulatoren für die Behandlung und/oder Prophylaxe von Entzündungs- und Autoimmunerkrankungen sowie hämatologisch- onkologischer Erkrankungen, beschrieben.
Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines
作者:Neil V. Harris、Christopher Smith、Keith Bowden
DOI:10.1021/jm00163a067
日期:1990.1
observed qualitative structure-activity relationships is proposed. The inhibitory activities of the compounds against the growth of intact bacterial cells in vitro closely parallel those for the inhibition of the isolated bacterial enzymes, suggesting that their antifolate action is responsible for their antibacterial effects. Five of the compounds were tested for their ability to cure a systemic E